Moreover, the epigenetic modifier Ezh2 was found to maintain H3K27me3-mediated repression of the FOXC1 gene in Luminal B breast cancer specifically, resulting in the process of metastatic behavior in both a mouse model and patient-derived xenografts (Hirukawa et al., 2018). The gene discussed is EZH2; the disease is breast carcinoma.